Arvelle Therapeutics is Drug Discovery in Switzerland that focus on operator business. Founded in 2019. They cover business area such as operator, innovative treatment, patient, CNS disorder, central nervous system disorder, neurological and neuromuscular disease, commercialization, cenobamate, clinician, proper medical care, focal seizure.
2019
( 5 years old in 2024 )
Operator
-
Zählerweg 6
6301 Zug
Switzerland
Private
operatorinnovative treatmentpatientCNS disordercentral nervous system disorderneurological and neuromuscular diseasecommercializationcenobamateclinicianproper medical carefocal seizure
* We use standard office opening hours in near Arvelle Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Arvelle Therapeutics is Drug Discovery business from Switzerland that founded in 2019 (5 years old in 2024), Arvelle Therapeutics business is focusing on Operator.
Arvelle Therapeutics headquarter office and corporate office address is located in Zählerweg 6 6301 Zug Switzerland.
Arvelle Therapeutics was founded in Switzerland.
In 2024, Arvelle Therapeutics is currently focus on operator sector.
Above is snippet of Google Trends for "operator" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Arvelle Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.